The Food and Drug Administration places a clinical hold! Inovio Pharmaceuticals' (NASDAQ: INO) shares nosedive! The end is near!While the first two overly punctuated statements are true, the last one isn't. (At least, I don't think it is.) Yes, the FDA recently put a clinical hold on a late-stage study planned by Inovio.